Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UFP TechnologiesFRA:UFP -2.46%94 3-Year EBITDA Growth Rate is 17.60% as of Jun. 2026, which is 21% above its 10-year median of 14.55. GuruFocus rates FRA:UFP with a GF Score™ of 94/100 and a GF Value™ of €237.24 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 690 Medical Devices & Instruments companies, UFP Technologies ranks better than 63.33% on this metric.
During the past 12 months, UFP Technologies's average EBITDA Per Share Growth Rate was -5.90% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 17.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 36.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 21.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of UFP Technologies was 87.60% per year. The lowest was -50.00% per year. And the median was 14.55% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
UFP Technologies 3-Year EBITDA Growth Rate Related Terms
FRA:UFP vs ALMR, BFLY, NEOG: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, UFP Technologies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UFP Technologies 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, UFP Technologies's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where UFP Technologies's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 17.60% mean?
UFP Technologies (FRA:UFP) has a 3-Year EBITDA Growth Rate of 17.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for UFP Technologies and its competitors. This is 21% above median its historical median of 14.55. According to the industry distribution chart, UFP Technologies ranks #253 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 36.7%.
Is UFP Technologies' 3-Year EBITDA Growth Rate too high?
UFP Technologies' current 3-Year EBITDA Growth Rate of 17.60% is 21% above median its 10-year median of 14.55. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 8.10. UFP Technologies' value of 17.60% is 117.3% above this industry median. Based on the distribution chart, UFP Technologies ranks #253 out of 690 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, UFP Technologies has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does UFP Technologies' 3-Year EBITDA Growth Rate compare to ALMR and BFLY?
According to the Medical Devices & Instruments industry distribution chart, UFP Technologies ranks #253 out of 690 companies for 3-Year EBITDA Growth Rate. This puts UFP Technologies in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.10. UFP Technologies' value of 17.60% is 117.3% above this benchmark. While the company's 10-year median is 14.55 vs. the industry median of 8.10, UFP Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 8.10, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UFP Technologies's current 3-Year EBITDA Growth Rate of 17.60% is 117.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for UFP Technologies and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 8.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UFP Technologies's current 3-Year EBITDA Growth Rate is 17.60%, which is 21% above median its own 10-year median of 14.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UFP Technologies stock overvalued right now?
Based on GuruFocus' analysis, UFP Technologies (FRA:UFP) is currently considered Modestly Overvalued. The stock's GF Value™ is €237.24, compared to a current price of €270.00 — trading 13.8% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 17.60%, which is 21% above median its 10-year median of 14.55 and 117.3% above the Medical Devices & Instruments industry median of 8.10. UFP Technologies' overall GF Score™ is 94/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For UFP Technologies (FRA:UFP), the current 3-Year EBITDA Growth Rate is 17.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UFP Technologies (FRA:UFP) Overvalued in 2026?
Based on GuruFocus' analysis, UFP Technologies stock appears to be overvalued.
The current stock price of €270.00 is trading 13.8% above its estimated GF Value™ of €237.24.
GuruFocus considers UFP Technologies to be Modestly Overvalued.
Key valuation signals for FRA:UFP:
3-Year EBITDA Growth Rate: 17.60% (21% above median its 10-year median of 14.55)
GF Value™: €237.24 vs. price of €270.00 (13.8% above fair value)
Industry Position: 117.3% above the Medical Devices & Instruments median (#253 of 690)
No single metric tells the full story. See the FRA:UFP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
94GF Score
Get the complete analysis for FRA:UFP
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UFP has been successfully added to your 
